LONDON (dpa-AFX) - British drug major AstraZeneca (AZN.L, AZN) Friday announced that its unit focused on rare diseases, Alexion Pharmaceuticals, Inc., is discontinuing CHAMPION-ALS, the global
Here's What Recent News From the FDA Means for AstraZeneca fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca drug added in Alexion acquisition falls short in pivotal ALS trial medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
Investegate |Zealand Pharma Announcements | Zealand Pharma: Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.